Clinical Trial Update: A Study Evaluating the Safety and Efficacy of QGE031 in Atopic Dermatitis Patients [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the safety and efficacy of QGE031 in patients with atopic dermatitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• QGE031

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED